Skip to main content

Table 2 Univariable logistic regression model of Neutrophil-lymphocyte ratio with regard to response to therapy (n = 247)

From: Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Risk factor β Odds ratio (95 % CI) p
Neutrophil-lymphocyte ratio (NLR) 0.087 1.091 (1.019-1.167) 0.012
  1. Abbreviations: CI confidence interval, β regression coefficient, response to therapy = Sinn score 1–4